Current scenario on non-nucleoside reverse transcriptase inhibitors  (2018-present) - ScienceDirect

Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect

5
(337)
Write Review
More
$ 18.50
Add to Cart
In stock
Description

Current scenario on non-nucleoside reverse transcriptase

The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside

Nonnucleoside Reverse Transcriptase Inhibitor - an overview

PDF) Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral

Current scenario on non-nucleoside reverse transcriptase

Current scenario on non-nucleoside reverse transcriptase

Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief

Development of a multiassay algorithm (MAA) to identify recent HIV

Current scenario on non-nucleoside reverse transcriptase

The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside

PDF) Strategies for the Design of HIV-1 Non-Nucleoside Reverse

Insights into SARS-CoV-2 genome, structure, evolution

Current scenario on non-nucleoside reverse transcriptase

Synthesis and biological evaluation of dihydroquinazoline-2-amines